Actively Recruiting
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
Led by University of Massachusetts, Worcester · Updated on 2025-11-26
50
Participants Needed
1
Research Sites
204 weeks
Total Duration
On this page
Sponsors
U
University of Massachusetts, Worcester
Lead Sponsor
N
National Heart, Lung, and Blood Institute (NHLBI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Chronic Obstructive Pulmonary Disease (COPD) is a serious lung condition that affects millions of people in the United States. Each year, it leads to about 150,000 deaths, nearly 900,000 emergency room visits, and 700,000 hospital stays. When COPD symptoms suddenly get worse-called an exacerbation-it can seriously harm a person's quality of life and often requires emergency care. Treating these flare-ups early can help prevent hospital visits, but right now, there aren't many good ways to make sure people get care quickly. Mobile Integrated Health (MIH) programs send specially trained paramedics, guided remotely by doctors, to care for patients in their homes. This approach could help people with COPD get faster, more effective care without needing to go to the hospital. In this project, the investigators are testing a new program called PEACE (Paramedic Evaluation for Acute COPD Exacerbation). The PEACE program sends community paramedics to patients' homes-when needed and in partnership with their regular doctors-to manage worsening COPD symptoms early. The study team will adapt the PEACE program to meet the needs of adults living at home with moderate to severe COPD, gather feedback from patients and healthcare providers, and run a small pilot study to see if the program is practical and helpful.
CONDITIONS
Official Title
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of COPD
- At least one COPD exacerbation leading to emergency department use in the past 6 months
- COPD GOLD Score letter B, C, or D
- Receives care at UMass Memorial Medical Center Pulmonary Clinic or Benedict Family Health Clinic
- Age 18 years or older
- Speaks English
- Lives within the geographical area covered by the UMass Memorial Medical Center MIH Program license
You will not qualify if you...
- No diagnosis of COPD
- Under 18 years of age
- Does not speak English
- Pregnant
- Unable to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Massachusetts Chan Medical School
Worcester, Massachusetts, United States, 01655
Actively Recruiting
Research Team
L
Laurel O'Connor, MD, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here